SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
OKYO Pharma Ltd
@OKYO_InsiderForm 4 Filing: Patil Rajkumar V. Acquires (Grant) $5,010.87 of $OKYO
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
OKYO Pharma Ltd
Ticker: $OKYO
Transaction Value
$5,010.87
Price/Share: $1.49
transaction date
2026-07-27
Shares: 3,363
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Patil Rajkumar V., holds the title of Chief Scientific Officer at OKYO Pharma Ltd.
On 2026-07-27, the insider transacted 3,363 shares.The shares were transacted at a weighted average price of $1.49 per share, resulting in a total market-relevant value of $5,010.87.
Executive Summary Summary
Patil Rajkumar V. (Chief Scientific Officer) was granted $5K of $OKYO
Post-Transaction Position: 20,030 shares
SEC Accession No: 0001493152-26-035212 (CIK: 2124067)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.